Pennsylvania bill seeks clinical research on psychedelics
Mental Health Weekly January 14, 2022 DOI: 10.1002/mhw.33077 via OpenAlex
Summary
AI-generated from the abstractIn Pennsylvania, a bill was introduced last fall to create a legal foundation for clinical studies of psilocybin or mushrooms. The legislation would provide funding for clinical trials aimed at treating post-traumatic stress disorder (PTSD) in veterans and first responders.
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Legislation Psychiatry Clinical trial Posttraumatic stress |
| Key finding | A Pennsylvania bill would fund clinical trials of psilocybin for PTSD in veterans and first responders. |
Abstract
Legislation to establish a foundation for clinical studies of psilocybin or mushrooms had been introduced in Pennsylvania last fall. The bill would fund clinical trials to address post‐traumatic stress disorder (PTSD) in veterans and first responders.